HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
批准号:
8365246
负责人:
Richard J. Barohn
金额:
$83.5万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-02-29
中文摘要
该子项目是对CTSA供资的百分比的估计,
用于广泛的研究领域(艾滋病研究,儿科研究,或
临床试验)。 列出的总成本仅为CTSA金额的估算
用于该研究领域的基础设施,而不是直接提供的资金
向子项目或子项目工作人员提供NCRR补助金。
堪萨斯大学中心地带临床和转化研究所(CTTR)成立于2007年,以响应国家CTSA倡议。该研究所的愿景是通过创建一个新颖的和变革性的转化研究企业,从板凳到床边到社区,以改善堪萨斯州人的健康。我们的药物研发计划的特别优势是一个创业药物和设备发现和开发计划,以及一个完善和高度完成的基于社区的研究计划。该研究所的具体目标是:1)为临床和翻译研究者创建一个新的学术家园,提供创新的培训计划; 2)提供增强的协调翻译研究基础设施; 3)通过利用和扩大现有网络,积极参与社区开发,测试和传播研究,以改善所有堪萨斯州人的健康。特别是在农村、服务不足和其他目标社区。拟议的基础设施和教育计划将通过增强和整合现有资源以更容易获得,开发新的创新资源,并利用位于大学研究中心的资源来解决临床和翻译研究人员面临的挑战包括我们的KINBRE和五个COBRE赠款和我们的KINBRE网络机构。为了支持我们的目标,我们已经在规划,开发和建立可再生能源技术方面汇集了一系列令人印象深刻的机构,企业和社区资源。该研究所将提供新的基础设施和培训及教育计划,以支持研究人员的临床和转化研究,将实验室发现用于首次人体试验(T1研究),并将研究转移到研究结果的传播和实施实践(T2研究)。在非凡的机构和社区支持下,我们已经取得了巨大进展。来自CTSA计划的资金将使堪萨斯大学有机会充分发挥其潜力,不仅为我们的地区,而且还为国家CTSA联盟做出贡献。(见说明):堪萨斯大学中心地带临床和转化研究所是临床和转化研究的学术之家,为科学家提供支持,并让社区参与,以便使发现和研究成果|我将更快地被送到护理点,从而改善所有堪萨斯州人的健康。
英文摘要
This subproject represents an estimate of the percentage of the CTSA funding that is
being utilized for a broad area of research (AIDS research, pediatric research, or
clinical trials). The Total Cost listed is only an estimate of the amount of CTSA
infrastructure going towards this area of research, not direct funding provided by
the NCRR grant to the subproject or subproject staff.
The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was established in 2007 in response to the national CTSA initiative. The vision of the HICTR is to improve the health of Kansans by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device discovery and development program and a well-developed and highly accomplished community-based research program. The specific aims of the HICTR are to: 1) create a new academic home with innovative training programs for clinical and translational Investigators; 2) provide an enhanced coordinated translational research infrastructure; and 3) actively engage the community in developing, testing, and disseminating research, by capitalizing on and expanding existing networks, to improve the health of all Kansans¿especially those in rural, underserved and other target communities. The proposed infrastructure and educational programs of the HICTR will address the challenges facing clinical and translational investigators by enhancing and integrating existing resources for easier access, developing new innovative resources, and capitalizing on resources residing in research centers across the university¿including our KINBRE and five COBRE grants~and our HICTR network institutions. In support of our aims, we have marshaled an impressive array of institutional, corporate, and community resources in planning, developing, and establishing the HICTR. The HICTR will provide new infrastructure and training and educational programs to support investigators' clinical and translational research¿taking laboratory discoveries to first trials in humans (Tl research) and moving research through to studies on dissemination and implementation of research findings to practice (T2 research). With extraordinary institutional and community support, we already have made tremendous progress. Funding from the CTSA program will allow the University of Kansas' HICTR the opportunity to fully realize its potential not only for our region, but also to contribute to the national CTSA Consortium.RELEVANCE (See Instructions): The University of Kansas Heartland Institute for Clinical and Translational Research is an academic home for clinical and translational research, providing support to scientists and involving the community, so that discoveries and research findings wi|l be brought more rapidly to the point of care, thus improving the health of all Kansans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9560956
-
项目类别:
-
资助金额:$402.38万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9514338
-
项目类别:
-
资助金额:$406.37万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Models of Neuromuscular Disease Across the Lifespan
-
批准号:9195818
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2016
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8644497
-
项目类别:
-
资助金额:$130.54万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8569903
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8683099
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8731286
-
项目类别:
-
资助金额:$105.9万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9341908
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:10242456
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8355588
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8543461
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9132606
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8242137
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8270452
-
项目类别:
-
资助金额:$319.78万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365250
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8365247
-
项目类别:
-
资助金额:$185.55万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8473932
-
项目类别:
-
资助金额:$310.84万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8337820
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8262012
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8869066
-
项目类别:
-
资助金额:$63.22万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
海外基金